{
    "code": "01049625",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049625",
    "time": "2018-03-30 03:49:49",
    "許可證字號": "衛署藥製字第049625號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/28",
    "發證日期": "97\/08\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104962507",
    "中文品名": "“生達”格理醣膜衣錠 4 毫克",
    "英文品名": "Rosiglit F.C. Tablets 4mg“Standard”(Rosiglitazone)",
    "適應症": "Rosiglitazone是一種thiazolidinedione類之抗糖尿病藥品，適用於與飲食控制及運動配合治療，以改善第二型糖尿病成人患者的血糖控制效果。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝 2~1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ROSIGLITAZONEMALEATE"
    ],
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "0510620200  生達化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0510620300  生達化學製藥股份有限公司",
        "製造廠廠址": "台南市新營區土庫里土庫６之２０號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400810",
            "成分名稱": "ROSIGLITAZONE MALEATE",
            "含量描述": "",
            "含量": "5.3000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "2211510 S0401Rosiglit 格理醣-LT-104-12-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049625&Seq=012&Type=9"
        },
        {
            "title": "2711516 S0208 Rosiglit 30錠BOX-104-12-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049625&Seq=012&Type=8"
        }
    ]
}